Literature DB >> 19807721

The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder.

H-C Steinhausen1.   

Abstract

OBJECTIVE: Attention-deficit / Hyperactivity Disorder (ADHD) is a frequent mental disorder with onset in childhood and persistence into adulthood in a sizeable number of people. Despite a rather simple clinical definition, ADHD has many facets because of frequent co-morbid disorders and varying impact on psychosocial functioning. Thus, there is considerable heterogeneity in various domains.
METHOD: A review of recent research findings in: i) selected domains of aetiology reflecting the role of genes, brain structures and functioning and the interplay of causal factors and ii) clinical heterogeneity in terms of co-morbidities, gender effects, courses and outcomes.
RESULTS: Molecular genetic studies have identified a number of candidate genes which have a small effect on behavioural variation in ADHD. In the most recent Genome Scan Meta Analysis of seven ADHD linkage studies, genome-wide significant linkage was identified on chromosome 16. The volume of both the total brain and various regions including the prefrontal cortex, the caudate nucleus and the vermis of the cerebellum is smaller in ADHD. Functional MRI has documented a specific deficit of frontostriatal networks in ADHD. Integrative aetiological models have to take the interaction of gene and environment on various dysfunctions into account. Clinical heterogeneity results from frequent associations with various co-morbidities, the impact of the disorder on psychosocial functioning, and gender effects. Partly, these effects are evident also in the course and outcome of ADHD.
CONCLUSION: ADHD is a chronic mental disorder with a complex aetiology. So far, various neurobiological factors have been identified that need to be studied further to better understand their interaction with environmental factors. The clinical presentation and the long-term course of ADHD are manifold.

Entities:  

Mesh:

Year:  2009        PMID: 19807721     DOI: 10.1111/j.1600-0447.2009.01446.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  18 in total

1.  Age, academic performance, and stimulant prescribing for ADHD: a nationwide cohort study.

Authors:  Helga Zoëga; Unnur A Valdimarsdóttir; Sonia Hernández-Díaz
Journal:  Pediatrics       Date:  2012-11-19       Impact factor: 7.124

2.  Prefrontal and parietal correlates of cognitive control related to the adult outcome of attention-deficit/hyperactivity disorder diagnosed in childhood.

Authors:  Kurt P Schulz; Xiaobo Li; Suzanne M Clerkin; Jin Fan; Olga G Berwid; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  Cortex       Date:  2017-02-20       Impact factor: 4.027

3.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

4.  Investigation of a developmental pathway from infant anger reactivity to childhood inhibitory control and ADHD symptoms: interactive effects of early maternal caregiving.

Authors:  Natalie V Miller; Amie A Hane; Kathryn A Degnan; Nathan A Fox; Andrea Chronis-Tuscano
Journal:  J Child Psychol Psychiatry       Date:  2019-03-25       Impact factor: 8.982

Review 5.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 6.  A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.

Authors:  Tamás Treuer; Susan Shur-Fen Gau; Luis Méndez; William Montgomery; Julie A Monk; Murat Altin; Shenghu Wu; Chaucer C H Lin; Héctor J Dueñas
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-04-06       Impact factor: 2.576

Review 7.  Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.

Authors:  Wim Verbeeck; Geertruida E Bekkering; Wim Van den Noortgate; Cornelis Kramers
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02

8.  Stimulant use for ADHD and relative age in class among children in Israel.

Authors:  Moshe B Hoshen; Arriel Benis; Katherine M Keyes; Helga Zoëga
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-01-29       Impact factor: 2.890

9.  Influence of candidate genes on attention problems in children: a longitudinal study.

Authors:  Catherina E M van Beijsterveldt; Christel M Middeldorp; Margarita C T Slof-Op't Landt; Meike Bartels; Jouke-Jan Hottenga; H Eka D Suchiman; P Eline Slagboom; Dorret I Boomsma
Journal:  Behav Genet       Date:  2010-10-30       Impact factor: 2.805

10.  Comorbid externalising behaviour in AD/HD: evidence for a distinct pathological entity in adolescence.

Authors:  Sharnel Perera; David Crewther; Rodney Croft; Hannah Keage; Daniel Hermens; C Richard Clark
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.